Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: A long-term multi-cohort study
(Article)
Kocken, M. Helmerhorst, T.J.M. Meijer, C.J.L.M. Berkhof, J. Louwers, J.A. Nobbenhuis, M.A.E. Bais, A.G. Hogewoning, C.J.A. Zaal, A. Verheijen, R.H.M. Snijders, P.J.F.
|
2011-05-01
|
Post-treatment CIN: Randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease
(Article)
Bais, A.G. Eijkemans, M.J.C. Rebolj, M. Snijders, P.J.F. Verheijen, R.H.M. Ballegooijen, M. van Meijer, C.J.L.M.
|
2009-02-15
|
Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls
(Article)
Bais, A.G. Beckmann, I. Ewing, P.C. Eijkemans, M.J.C. Meijer, C.J.L.M. Snijders, P.J.F. Helmerhorst, T.J.M.
|
2007-12-01
|
Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies
(Article)
Rebolj, M. Bais, A.G. Ballegooijen, M. van Boer, R. Meerding, W.J. Helmerhorst, T.J.M. Habbema, J.D.F.
|
2007-10-01
|
Risk reduction by HPV-Testing in Women with Premalignant Cervical Lesions: Studies of clinical management and observations on the immunological background
(Doctoral Thesis)
Bais, A.G.
|
2007-09-12
|
Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
(Article)
Bais, A.G. Kemenade, F. van Berkhof, J. Verheijen, R.H.M. Snijders, P.J.F. Voorhorst, F. Babović, M. Ballegooijen, M. van Helmerhorst, T.J.M. Meijer, C.J.L.M.
|
2007-04-01
|
A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions
(Article)
Bais, A.G. Beckmann, I. Lindemans, J. Ewing, P.C. Meijer, C.J.L.M. Helmerhorst, T.J.M. Snijders, P.J.L.M.
|
2005-01-01
|